Effects of Vitamin B3 in Patients With Ataxia Telangiectasia
Sponsor: Radboud University
Collaborators: A-T Children’s Project, Twan Foundation
Purpose
To investigate the effects of nicotinamide riboside (vitamin B3) on the disease course of patients with ataxia telangiectasia.
Study Design
Open label proof of concept, single group
Dose
25mg/kg/day
Length of Intervention
4 months on NR; total duration 6 months
Intrinsic Capacity
Locomotion
Status
Unknown
Condition or Disease
Ataxia Telangiectasia
Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.